伊马替尼治疗初发慢性髓性白血病慢性期患者获得分子学反应的临床预测模型

OBJECTIVE: To develop a scoring system to predict molecular responses in patients with chronic myeloid leukemia in the chronic phase（CML-CP）receiving initial imatinib therapy. METHODS: Data from consecutive adults with newly diagnosed CML-CP treated by initial imatinib was interrogated and subjects...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2023
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033272/
https://www.ncbi.nlm.nih.gov/pubmed/36948863
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.02.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10033272/
https://www.ncbi.nlm.nih.gov/pubmed/36948863
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.02.004

Ejemplares similares